Abstract
Both hepatitis B virus (HBV) and hepatitis C virus (HCV) can cause persistent viral infection in humans. Chronic infection is associated with a risk of cirrhosis and hepatocellular carcinoma. The cause of chronic infection is unknown. A large body of evidence suggests that a failure of the adaptive immune response is critical in the establishment of chronic infection. Recently a new group of T cells (T-regulatory cells), that express CD4 +CD25+ and Foxp3, which can inhibit the cellular (CD4 +/CD8+) immune response have been described. In this review the authors explore the thoughts regarding immune responses to HBV and HCV infections and the role of these T-regulatory cells in relation to the pathogenesis of chronic HBV and HCV infection and the potential for therapeutic intervention.
| Original language | English |
|---|---|
| Pages (from-to) | 1689-1703 |
| Number of pages | 15 |
| Journal | Expert Opinion on Biological Therapy |
| Volume | 7 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- FoxP3
- Hepatitis B
- Hepatitis C
- Regulatory T cells
- Viral hepatitis
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver